The global market for regenerative medicine is projected to reach almost $50 billion by 2021, according to a Market Data Forecast report.
1. The global regenerative medicine market is expected to reach $48.9 billion by 2021, growing at a CAGR of 23.24 percent.
2. Key players in the market include Acelity, Celgene, NuVasive, StemCells and Vertex Pharmaceuticals.
3. The surge in market growth is attributed to technological advancements and demand for biologically derived materials, along with government support for tissue engineering therapies.